Foghorn Therapeutics Inc. Capital Expenditures Incurred but Not yet Paid
Foghorn Therapeutics Inc. (FHTX) reported Capital Expenditures Incurred but Not yet Paid of $35.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-05-07
- Foghorn Therapeutics Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $35.00K.
- Foghorn Therapeutics Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $0.00.
- Foghorn Therapeutics Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Foghorn Therapeutics Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Foghorn Therapeutics Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Foghorn Therapeutics Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $22.00K, a 37.14% decline from fiscal 2023.
- Foghorn Therapeutics Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $35.00K, a 78.13% decline from fiscal 2022.
- Foghorn Therapeutics Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $160.00K, a 45.76% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-03-31 | $35.00K 10-Q · filed 2026-05-07 | $35.00K derived: sum of 2 quarters · filed 2026-05-07 | $35.00K derived: sum of 3 quarters · filed 2026-05-07 | $35.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $0.00 derived: sum of 2 quarters · filed 2026-03-11 | $0.00 derived: sum of 3 quarters · filed 2026-03-11 | $0.00 10-K · filed 2026-03-11 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | -$267.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | -$267.00K derived: sum of 3 quarters · filed 2026-05-07 | -$90.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | -$267.00K derived: sum of 2 quarters · filed 2026-05-07 | -$90.00K derived: sum of 3 quarters · filed 2026-05-07 | $22.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$267.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$90.00K derived: sum of 2 quarters · filed 2026-03-11 | $22.00K derived: sum of 3 quarters · filed 2026-03-11 | $22.00K 10-K · filed 2026-03-11 |
| 2024-09-30 | $177.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $289.00K derived: sum of 2 quarters · filed 2025-11-05 | $289.00K 10-Q · filed 2025-11-05 | $266.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $112.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $112.00K 10-Q · filed 2025-08-05 | $89.00K derived: sum of 3 quarters · filed 2025-08-05 | $60.00K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-06 | -$23.00K derived: sum of 2 quarters · filed 2025-03-06 | -$52.00K derived: sum of 3 quarters · filed 2025-03-06 | -$263.00K derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-12-31 | -$23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$52.00K derived: sum of 2 quarters · filed 2025-03-06 | -$263.00K derived: sum of 3 quarters · filed 2025-03-06 | $35.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | -$29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | -$240.00K derived: sum of 2 quarters · filed 2024-11-04 | $58.00K 10-Q · filed 2024-11-04 | $14.00K derived: sum of 4 quarters · filed 2024-11-04 |
| 2023-06-30 | -$211.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $87.00K 10-Q · filed 2024-08-08 | $43.00K derived: sum of 3 quarters · filed 2024-08-08 | $37.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $298.00K 10-Q · filed 2024-05-06 | $254.00K derived: sum of 2 quarters · filed 2024-05-06 | $248.00K derived: sum of 3 quarters · filed 2024-05-06 | $219.00K derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | -$44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$50.00K derived: sum of 2 quarters · filed 2024-03-07 | -$79.00K derived: sum of 3 quarters · filed 2024-03-07 | $160.00K 10-K · filed 2024-03-07 |
| 2022-09-30 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$35.00K derived: sum of 2 quarters · filed 2023-11-02 | $204.00K 10-Q · filed 2023-11-02 | $490.00K derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | -$29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $210.00K 10-Q · filed 2023-08-04 | $496.00K derived: sum of 3 quarters · filed 2023-08-04 | $430.00K derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $239.00K 10-Q · filed 2023-05-08 | $525.00K derived: sum of 2 quarters · filed 2023-05-08 | $459.00K derived: sum of 3 quarters · filed 2023-05-08 | -$425.00K derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $286.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $220.00K derived: sum of 2 quarters · filed 2023-03-09 | -$664.00K derived: sum of 3 quarters · filed 2023-03-09 | $295.00K 10-K · filed 2023-03-09 |
| 2021-09-30 | -$66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$950.00K derived: sum of 2 quarters · filed 2022-11-08 | $9.00K 10-Q · filed 2022-11-08 | -$4.19M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$884.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $75.00K 10-Q · filed 2022-08-09 | -$4.13M derived: sum of 3 quarters · filed 2022-08-09 | -$640.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $959.00K 10-Q · filed 2022-05-09 | -$3.24M derived: sum of 2 quarters · filed 2022-08-09 | $244.00K derived: sum of 3 quarters · filed 2022-08-09 | $1.89M derived: sum of 4 quarters · filed 2022-08-09 |
| 2020-12-31 | -$4.20M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-08-09 | -$715.00K derived: sum of 2 quarters · filed 2022-08-09 | $929.00K derived: sum of 3 quarters · filed 2022-08-09 | $2.40M 10-K/A · filed 2022-08-09 |
| 2020-09-30 | $3.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $5.13M derived: sum of 2 quarters · filed 2021-11-09 | $6.60M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $3.12M 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | $1.47M 10-Q · filed 2021-05-11 | |||
| 2019-12-31 | $367.00K 10-K · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |